Elicio Therapeutics, Inc.

ELTX

—

Advanced chart & tools →

Elicio Therapeutics, Inc.ELTX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-2.58

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$2.30M

Net income

$-39.57M

Net margin

-1719.7%

Gross margin

—

Dividends & financials

Elicio Therapeutics, Inc. (ELTX) reported revenue of $2.30M and net income of $-39.57M, or $-2.58 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.